Orgovyx

Active Ingredient(s): Relugolix
FDA Approved: * December 18, 2020
Pharm Company: * MYOVANT SCIENCES
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Orgovyx Overview

Relugolix, sold under the brand names Orgovyx and Relumina, is a gonadotropin-releasing hormone antagonist (GnRH receptor antagonist) medication which is used in the treatment of prostate cancer in men and uterine fibroids in women.[2][3][4][1] It is also under development for use in the treatment of endometriosis.[3][5][6][7][8][9]&am...

Read more Orgovyx Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Relugolix

Recent Orgovyx Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Relugolix
  • Tablet: 120mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Relugolix or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA